Publications- Dr Kathy Flitcroft

Due to copyright restrictions, only selected full-text articles are available on this website. A copy for your personal use can be obtained through the journal or is available by emailing the author Kathy.Flitcroft@melanoma.org.au.

2018

Oh DD, Flitcroft K, Brennan ME, Snook K, Spillane AJ.  Outcomes of breast reconstruction in older women: Patterns of uptake and clinical outcomes in a large metropolitan practice. (under review)

Azimi F, Flitcroft K, Mathieu E, Karantonis R, Snook K, Spillane A. Low level laser treatment is ineffective for capsular contracture. Results of the LaTCon randomised controlled trial. [Accepted December 2017, Plastic & Reconstructive Surgery].

2017

Flitcroft K, Brennan M, Costa D, Spillane A. Regional variation in immediate breast reconstruction rates in Australia. BJS Open, 2017. 1: 114–121. DOI: 10.1002/bjs5.19

Flitcroft K, Brennan M, Spillane A. Women’s expectations of breast reconstruction following mastectomy for breast cancer. A systematic review. Support Care Cancer. 2017 Aug;25(8):2631-2661.

Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: A systematic review of patient-reported factors influencing choice. Qual Life Res. 2017 Sep;26(9):2287-2319.

2016

Brennan ME, Flitcroft K, Warrier S, Snook K, Spillane AJImmediate expander/implant breast reconstruction followed by post-mastectomy radiotherapy for breast cancer: Aesthetic, surgical, satisfaction and quality of life outcomes in women with high-risk breast cancer. The Breast 2016;30:59–65. Abstract

Flitcroft K, Brennan M, Costa D, Spillane A. Documenting patterns of access to breast reconstruction in Australia: The National Picture. The Breast 2016; 30: 47-53. Abstract

Flitcroft K, Brennan M, Costa D, Wong A, Snook K and Spillane A. An evaluation of factors affecting preference for immediate, delayed or no breast reconstruction in women with high-risk breast cancer. Psycho-oncology 2016; 25(12):1463-1469. Abstract

Flitcroft K, Brennan M, Spillane A. The difficulties of sourcing Australian health data: The case of breast reconstruction. ANZ Journal of Surgery, 2016 Jul;86(7-8):537-9. Link to journal

Oh DD, Flitcroft K, Brennan ME, Spillane AJ. Patterns and outcomes of breast reconstruction in older women – a systematic review of the literature. EJSO 2016;42(5):604-615.  Abstract

Winters Z, Azfal M, Rumpold G, Holzner B, Oberguggenburger A, Da Costa Vieira R, Hartnup S, Flitcroft K, Bjelic-Radisic V, Panouilleres M, Rydevik-Mani M, King M, Rutherford C. International validation of the EORTC Patient-Reported Outcome Measure (PROM) in breast reconstruction (BRR): Evaluating health related quality of life (HRQL) and clinical effectiveness. Eur J Surg Oncol 2016. DoI: http://dx.doi.org/10.1016.ejso.2016.02.042 Abstract

2015

Wortley S, Flitcroft K, Howard, K.  The role of preference information in health technology assessment decision-making. International Journal of Technology Assessment in Health Care 2015;31(4):241-248.

Read R, Flitcroft K, Snook K, Boyle F, Spillane A. The utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ Journal of Surgery. 2015;85(5):315-20. Abstract

2014

Brennan ME, Spillane AFlitcroft K, Snook K, Wong A. Platinum multidisciplinary breast cancer care or platinum breast reconstruction? ANZJS 2014;84(9):604-605. Journal

Flitcroft KLSpillane AJRead RL. Lack of appropriate imaging before breast augmentation can have serious patient consequences. Med J Aust. 2014 Mar 3;200(4):198-9. Journal

Wong A, Snook K, Brennan M, Flitcroft K, Tucker M, Hiercz D, Spillane A. Increasing breast reconstruction rates by offering more women a choice. ANZ Journal of Surgery 2014;84:31-36. Journal

2013

Flitcroft KL, Gillespie JA, Carter SM, Salkeld GP, Trevena LJ. Incorporating evidence and politics in health policy: Can institutionalising evidence review make a difference? Evidence & Policy: 29 November 2013. Abstract

2012

Flitcroft KL, Irwig LM, Carter SM, Salkeld GP, Gillespie JA. Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology  2012;12: e183. Free full text pdf

2011

Flitcroft KL, St John DJ, Howard K, Carter SM, Pignone MP, Salkeld GP, Trevena LJ. A case study of bowel cancer screening in the UK and Australia: Evidence lost in translation?  Journal of Medical Screening 2011;18: 193-203. Free full text pdf

Flitcroft KL, Gillespie JA, Carter SM, Trevena LJ, Salkeld GP. When good evidence is not enough: the role of context in bowel cancer screening policy in New Zealand. Evidence & Policy 2011; 7(3): 307-26. Abstract

Pignone M, Flitcroft KL, Howard K, Trevena LJ, Salkeld GP, St John, DJ. Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Medical Journal of Australia 2011; 194(4): 180-185. Free full text pdf

Flitcroft KL, Gillespie JA, Carter SM, Salkeld GP, Trevena LJ, Getting research into policy: the need for deliberative strategies? Social Science & Medicine 2011; 72: 1039-1046. Abstract

2010

Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM. Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Medical Journal of Australia, 193 (1); 5 July 2010: 37-42. Abstract

2008

Entwistle VA, Carter SM, Trevena LJ, Flitcroft KL, Irwig LM, McCaffery K, Salkeld GP. Communicating about screening: a proposed new direction.  British Medical Journal, 337; 4 October 2008: 789-791.[No abstract] Journal

2007

Boxall AM, Flitcroft KL. From little things, big things grow: A local approach to system-wide maternity services reform in the absence of definitive evidence. Australia and New Zealand Health Policy 2007, 4:18. Free full text pdf

2006

Flitcroft KLBoxall AM. Maternity services options: A review of the evidence on alternative models of care.  Commissioned report for Sydney South West Area Health Service, Australian Health Policy Institute, 2006.